酒精性肝炎

  • 网络Alcoholic Hepatitis;r-GT
酒精性肝炎酒精性肝炎
  1. 70例急性酒精性肝炎的CT影像分析

    The imaging features in CT of patients with acute alcoholic hepatitis : An analysis of 70 cases

  2. 如果不戒酒,大多数酒精性肝炎患者最终将进展为肝硬化并死亡,Dr。

    Without abstinence , the majority of people with alcoholic hepatitis eventually develop cirrhosis and die , says Dr.

  3. 重症酒精性肝炎患者肝穿组织枯否细胞内抗LPS荧光显色亦显著低于正常对照。

    FITC fluorescent intensity in Kupffer cells in the liver samples of patients with acute severe alcoholic hepatitis was significantly lower than of normal controls .

  4. Shah说,依那西普疗法在动物模型上得到了肯定,可是在酒精性肝炎患者的治疗中却没有效果。

    Etanercept therapy showed promise in our animal models , but was not effective in treatment of patients with alcoholic hepatitis .

  5. 结论:清热利湿法对酒精性肝炎具有较好疗效,其机制可能与下调炎症细胞因子IL-8水平,减轻肝脏脂质过氧化反应等有关。

    Conclusion : MCHRD has better therapeutic effect on alcoholic hepatitis . The mechanism might be related to down regulating the level of inflammation cytokine IL 8 and relieving lipid peroxidation of liver .

  6. 研究发现,特异性肝细胞PTEN缺失不仅引起肝细胞癌,还导致与肝纤维化密切相关的非酒精性肝炎的发生。

    Studies demonstrated that the absence of PTEN in specific hepatic cells may result not only in hepatocellular carcinoma , but also in non-alcoholic steatohepatitis , which was closely related to hepatic fibrosis .

  7. 但骨桥蛋白与酒精性肝炎的关系以往尚无人研究。

    But a link to alcoholic hepatitis had not been explored .

  8. 酒精性肝炎与肝硬变的临床及预后观察

    Clinical and follow up studies on alcoholic hepatitis and alcoholic liver cirrhosis

  9. 酒精性肝炎在全世界范围内有很高的发病率和死亡率。

    Alcoholic hepatitis is a major cause of morbidity and mortality worldwide .

  10. 88例酒精性肝炎临床特征及疗效分析

    Clinical characteristics and curative effect analysis of 88 patients with alcoholic hepatitis

  11. 环氧合酶-2在实验性酒精性肝炎中的表达及作用机制

    Expression and effect of cyclooxygenase-2 in alcoholic hepatitis in rats

  12. 酒精性肝炎的药物治疗现状

    Recent Developments in Medical Therapy of Alcoholic Hepatitis

  13. 清热利湿法治疗酒精性肝炎疗效观察

    Observation on the Method of Clearing Heat and Removing Dampness in Treating Alcoholic Hepatitis

  14. 完全戒酒是治疗酒精性肝炎最重要的单一因素。

    Complete abstinence from alcohol is the single most important treatment for alcoholic hepatitis .

  15. 中西医结合治疗伴有黄疸的酒精性肝炎临床研究

    The Treatment of Alcoholic Hepatitis with Jaundice by the Combination of Chinese Traditional and Western Medicine

  16. 激素治疗酒精性肝炎的新预测因素:低度脂肪变性和门脉血流显著改变

    Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis

  17. 还原型谷胱甘肽对酒精性肝炎患者血清TNF-α、瘦素的影响

    Effect of reduced glutathione on serum leptin and TNF - α levels in patients with alcoholic hepatitis

  18. 目的:探讨狗胆对大鼠酒精性肝炎的防治作用。

    AIM : To investigate the preventive and therapeutic effects of dog bile on alcohol-related hepatitis in rats .

  19. 酒精性肝炎为第二位,占21.93%;

    70.32 % cases were correlative with hepatitis B.The second one is Alcoholic hepatitis ( 21.93 % ) .

  20. 非酒精性肝炎有时会导致肝硬化,这是损伤修复留下的疤痕组织。

    Nonalcoholic steatohepatitis can sometimes lead to cirrhosis of the lier , a scarring of tissue that impairs function .

  21. 研究结果发现接受依那西普的中重度酒精性肝炎患者的六个月死亡率显著增高。

    Research results found a significantly higher rate of six-month mortality in patients with moderate to severe alcoholic hepatitis who received etanercept .

  22. 国际肝病:您能给我们概括介绍一下目前治疗酒精性肝炎的进展吗?

    Hepatology Digest : Will you please give us your general over-view of the current progress in the treatment of alcoholic hepatitis ?

  23. 酒精性肝炎住院人数总体呈上升趋势,其中分别于2006年、2010年呈现2个高峰期。

    The ratio of alcoholic hepatitis inpatients showed a trend of escalation in overall , especially there were two booms in 2006 and 2010 .

  24. 结论:本方剂有较好的治疗酒精性肝炎的作用,对嗜酒成瘾者也能起到较好的保肝作用,可以在临床上推广应用。

    Conclusion : The recept has a relative good function in treating alcoholic hepatitis , it also can protect the liver for the alcohol addiction .

  25. 多种病因可导致肝纤维化,其中以病毒性肝炎、酒精性肝炎、非酒精性脂肪性肝炎、自身免疫性肝炎较为常见。

    There are many etiological agents of liver fibrosis , the most common of them are virus hepatitis , alcoholic hepatitis and non-alcoholic fatty liver .

  26. 目的:探讨利湿解毒法对酒精性肝炎的治疗作用,为临床治疗酒精性肝炎提供新思路。

    Objective : Through the treatment of eliminate wetness and disintoxication in alcoholic hepatitis , we try to find a new way of therapy in this disease .

  27. 肝脏移植是酒精性肝炎重症患者最佳的、也是最无奈的选择,但他仍然面临移植手术时机和患者适应症的选择问题。

    Until now hepatic transplantation is the best solution to the patients with severe alcoholic hepatitis , but the timing and indications for transplantation are still problematic .

  28. 酒精性肝炎往往导致肝硬化及肝癌,其重症患者短期死亡率相当高。

    Alcoholic hepatitis is a serious liver disease that may lead to cirrhosis and carcinoma , and the short-term mortality rate is fairly high in severe patients .

  29. 尽管这种治疗方法,但仍有30-35%的急性酒精性肝炎患者死于六个月内,因为可的松为基础的治疗仍然效果不足。

    Despite this treatment , 30-35 % of patients with acute alcoholic hepatitis still die within a six month period , since the cortisone-based treatment remains insufficient .

  30. 目的:观察酒精性肝炎患者使用还原型谷胱甘肽治疗后肝纤维化指标的改善情况及临床症状、体征、肝功能的变化。

    AIM : To observe the changes of hepatic fibrosis index , clinical symptom , physical sign and hepatic function after the patients were treated treatment with reduced glutathione hormone .